Fluocinonide
Fluocinonide is a very strong topical corticosteroid (steroid medicine for the skin) used to relieve redness, swelling and itching from steroid-responsive skin conditions, in creams, an ointment, a gel and a solution.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 54 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Fluocinonide is a very strong steroid for the skin that calms the inflammation and itching of conditions like psoriasis and eczema (atopic dermatitis), usually a step up when milder steroids fail, on the market since about 1989 and available as a generic. Short courses are well tolerated; most people notice only some burning or itching where it goes on, while overuse can thin the skin. Its boxed warning limits it to skin only, never the eyes, mouth or vagina, and keeps it off the face, groin and underarms. Use a thin layer and call your prescriber if the skin is not better within two weeks or looks infected.
Clinical pearls
- Do not seal treated skin under plastic wrap or airtight bandages unless told to, since covering it boosts how much is absorbed.
- Mention any other steroid creams or steroid medicines you use, because stacking steroids raises how much reaches your bloodstream.
- Stop once the skin clears rather than finishing the tube, since it is meant for flares, not daily upkeep.
- If you have diabetes, watch your sugars when treating large areas, since absorbed steroid can raise blood sugar.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
For skin use only. Do not get Fluocinonide Cream USP, 0.1% in your eyes, mouth or vagina. It is not for use on the face, groin or underarms.
Patient information guide A plain-language walkthrough of Fluocinonide, written from its FDA label.
What Fluocinonide is used for
▾
Fluocinonide treats inflammation and itching from steroid-responsive skin conditions.
- Vanos Cream, 0.1%, and other fluocinonide 0.1% creams: for people 12 and older.
- Fluocinonide Cream, 0.05%: relief of inflammation and itching of corticosteroid-responsive dermatoses.
- Fluocinonide Gel and Ointment, 0.05%: the same use.
- Fluocinonide Topical Solution, 0.05%: the same use.
How Fluocinonide works
▾
Corticosteroids play a role in cell signaling, immune function, inflammation and protein regulation. The precise way fluocinonide works in these skin conditions is unknown.
Fluocinonide dosage
▾
Fluocinonide is applied only to the skin, as a thin layer. Follow your prescriber and the product label.
- 0.1% creams (such as Vanos): once or twice daily for psoriasis, once daily for atopic dermatitis, once or twice daily for other conditions. Not beyond 2 consecutive weeks, and no more than 60 g per week.
- 0.05% cream, gel, ointment and solution: generally two to four times daily depending on severity.
- Occlusive dressings (airtight coverings) may be used with the 0.05% products for psoriasis or stubborn conditions, but stop them if infection develops.
Dosing details from the FDA-approved label
From the Fluocinonide prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Psoriasis (Vanos Cream / Fluocinonide Cream USP, 0.1%)
- Apply a thin layer once or twice daily to the affected skin areas as directed by a physician
- Twice-daily application has been shown to be more effective in achieving treatment success during 2 weeks of treatment
- Atopic dermatitis (Vanos Cream / Fluocinonide Cream USP, 0.1%)
- Apply a thin layer once daily to the affected skin areas as directed by a physician
- Once-daily application has been shown to be as effective as twice daily treatment in achieving treatment success during 2 weeks of treatment
- Corticosteroid responsive dermatoses, other than psoriasis or atopic dermatitis (Vanos Cream / Fluocinonide Cream USP, 0.1%)
- Apply a thin layer once or twice daily to the affected areas as directed by a physician
- Fluocinonide 0.05% cream, emulsified-base cream, gel, ointment and topical solution (general use)
- Generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition
- Occlusive dressings may be used for psoriasis or recalcitrant conditions; if an infection develops, discontinue occlusive dressings and institute appropriate antimicrobial therapy
Read the label’s full dosing text
2 DOSAGE AND ADMINISTRATION For topical use only. Fluocinonide cream USP, 0.1% is not for ophthalmic, oral, or intravaginal use. For psoriasis, apply a thin layer of fluocinonide cream USP, 0.1% once or twice daily to the affected skin areas as directed by a physician. Twice daily application for the treatment of psoriasis has been shown to be more effective in achieving treatment success during 2 weeks of treatment. For atopic dermatitis, apply a thin layer of fluocinonide cream USP, 0.1% once daily to the affected skin areas as directed by a physician. Once daily application for the treatment of atopic dermatitis has been shown to be as effective as twice daily treatment in achieving treatment success during 2 weeks of treatment [ see Clinical Studies ( 14 ) ]. For corticosteroid responsive dermatoses, other than psoriasis or atopic dermatitis, apply a thin layer of fluocinonide cream USP, 0.1% once or twice daily to the affected areas as directed by a physician. For topical use only. Fluocinonide cream USP, 0.1%is not for ophthalmic, oral, or intravaginal use. ( 2 ) Psoriasis: apply a thin layer once or twice daily to the affected skin areas. ( 2 ) Atopic Dermatitis: apply a thin layer once daily to the affected skin areas. ( 2 ) Corticosteroid Responsive Dermatoses, other than psoriasis or atopic dermatitis: apply a thin layer once or twice daily to the affected areas. ( 2 )
Read the full Dosage and Administration section on DailyMed →
Fluocinonide side effects
▾
Common effects are usually mild.
Common side effects
- Headache
- Burning at the application site
- Stuffy nose or cold-like symptoms (nasopharyngitis)
- Itching, irritation or redness where applied
- Dry skin or acne-like bumps
- Thinning of the skin or stretch marks
- Itching, irritation, dryness or redness
When to get medical help
- Call your doctor if the skin becomes irritated or the condition gets worse or does not improve within 2 weeks.
- Call your doctor if you develop a skin infection or signs of one in the treated area.
- Get medical help if you have signs of an allergic reaction, such as a rash that does not heal or worsens.
- Tell your doctor about symptoms of steroid absorption into the body, such as adrenal suppression, Cushing's syndrome or high blood sugar.
- In children, report slowed growth, delayed weight gain, or headaches with bulging soft spots on an infant's head.
Fluocinonide warnings and precautions
▾
- For skin use only. Keep it out of the eyes, mouth and vagina.
- Avoid the face, groin and underarms with the 0.1% creams.
- Absorption can suppress the adrenal system (HPA axis), cause Cushing's syndrome and raise blood sugar. This is usually reversible once the medicine stops.
- Risk is higher with large areas, long use, airtight dressings, damaged skin and liver failure.
- Local reactions such as skin thinning and stretch marks may be irreversible.
- If a skin infection is present or develops, an antifungal or antibacterial medicine is needed.
- Children are at greater risk of side effects.
Fluocinonide interactions
▾
No specific drug interactions are named, but one point matters.
- Other corticosteroid-containing products: using more than one at once can increase total absorption into the body.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Fluocinonide
▾
- Do not use if you are allergic to any ingredient.
- The 0.1% creams are not recommended under age 12.
- Do not use 0.1% creams for rosacea or perioral dermatitis.
- Pregnancy: use only if the benefit justifies the risk to the baby.
- Breastfeeding: talk with your doctor about whether to stop nursing or the medicine.
- Liver failure can raise the risk of adrenal suppression.
- Older adults: studies did not include enough people 65 and over to know if they respond differently.
Fluocinonide overdose
▾
Fluocinonide applied to the skin can be absorbed in amounts large enough to cause effects throughout the body. Use only as directed. Contact your doctor or poison control if you think too much was used.
What Fluocinonide does in the body
▾
In skin-blanching tests, fluocinonide 0.1% cream was in the super-high potency range among topical steroids. In studies, some adults and children had temporary adrenal (HPA axis) suppression after use. In the children studied, adrenal function returned to normal on follow-up testing 14 days after stopping.
How your body processes Fluocinonide
▾
How much steroid gets through the skin depends on the product vehicle and the condition of the skin. It can be absorbed through healthy skin. Inflammation, skin disease and airtight dressings increase absorption. Once absorbed, it is handled like steroid medicines taken by mouth: it binds to proteins in the blood, is broken down mainly in the liver, and is cleared by the kidneys, with some passing into bile.
How to store Fluocinonide
▾
Store at 20°-25°C (68°-77°F) . Store at controlled room temperature. Avoid excessive heat, above 40°C (104°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Fluocinonide: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Fluocinonide — the kind of thing our pharmacy team would talk through with you at the counter.
What is fluocinonide used for?
▾
How do I apply it?
▾
Can I use it on my face or groin?
▾
How long can I use it?
▾
What side effects should I watch for?
▾
Is it safe in pregnancy or for kids?
▾
Is Fluocinonide available over the counter?
▾
When was Fluocinonide first available?
▾
Who makes Fluocinonide?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Fluocinonide on HelloPharmacist
Fluocinonide forms and strengths (how it comes)
Fluocinonide is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Fluocinonide inactive ingredients by manufacturer.
Topical cream, ointment or gel
How this form is used
- Vanos Cream, 0.1%, relieves inflammation and itching from corticosteroid-responsive dermatoses in people 12 and older.
- Fluocinonide Cream, Gel and Ointment, 0.05%, relieve inflammation and itching from corticosteroid-responsive dermatoses.
- Vanos Cream is applied as a thin layer once or twice daily for psoriasis, or once daily for atopic dermatitis, as directed by a physician.
- Vanos Cream is not recommended beyond 2 consecutive weeks and should not be used on the face, groin or underarms.
- Fluocinonide Cream, Gel and Ointment, 0.05%, are generally applied as a thin film two to four times daily depending on severity.
- Fluocinonide 0.05% products may be used with occlusive dressings for psoriasis or stubborn conditions. Stop the dressings if infection develops.
Topical solution
How this form is used
- Fluocinonide Topical Solution, 0.05%, relieves inflammation and itching from corticosteroid-responsive dermatoses.
- Fluocinonide Topical Solution, 0.05%, is generally applied as a thin film two to four times daily depending on severity.
- Occlusive dressings may be used for psoriasis or stubborn conditions with fluocinonide solution. Stop them if infection develops.
Fluocinonide on the U.S. market: products, makers and brands
How Fluocinonide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
24 companies list 50 Fluocinonide product records with the FDA, mostly as topical cream, ointment or gel, topical solution; the earliest marketing or approval year on record is 1971. Brand names on the directory include Vanos, Fluocinol Pak; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (8) · Kit (2) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Fluocinonide is used (Medicaid data)
A general measure of how commonly Fluocinonide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Fluocinonide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Fluocinonide prescribed? Of the 1,601 medications we measure, Fluocinonide ranks #367 by Medicaid prescriptions — more than 77% of them.
Utilization by Fluocinonide product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
fluocinonide 0.5 MG/ML Topical Solution Most dispensed
Summed across the 10 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310364
fluocinonide 0.5 MG/ML Topical Cream
Summed across the 14 of 44 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 103456
fluocinonide 0.0005 MG/MG Topical Ointment
Summed across the 9 of 31 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 103457
fluocinonide 0.0005 MG/MG Topical Gel
Summed across the 5 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310362
Emollient fluocinonide 0.5 MG/ML Topical Cream
Summed across the 6 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1801283
fluocinonide 1 MG/ML Topical Cream
Summed across the 4 of 38 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 485647
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Fluocinonide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 48 of 173 listed Fluocinonide NDCs with Medicaid activity.
Compare Fluocinonide products
A representative set of FDA-listed product records for Fluocinonide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Topical cream, ointment or gel | ||||
| 0.5 mg/g | Topical | A-S Medication Solutions × 4 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 1 mg/g | Topical | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 0.05 mg/g | Topical | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Bryant Ranch Prepack × 4 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Cosette Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Encube Ethicals, Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 0.5 mg/g | Topical | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | NuCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Padagis Israel Pharmaceuticals Ltd | ANDA | View NDC → |
| 0.5 mg/g | Topical | Preferred Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 0.5 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 4 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.5 mg/g | Topical | Teva Pharmaceuticals USA, Inc. × 3 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Viona Pharmaceuticals Inc | ANDA | View NDC → |
| 0.05 mg/g | Topical | Xiromed LLC | ANDA | View NDC → |
| 1 mg/g | Topical | Zydus Lifesciences Limited | ANDA | View NDC → |
| 💊Topical solution | ||||
| 0.5 mg/mL | Topical | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 0.5 mg/mL | Topical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Lupin Pharmaceuticals,Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| 0.5 mg/mL | Topical | NorthStar RxLLC | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Novel Laboratories, Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Quagen Pharmaceuticals Llc | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Saptalis Pharmaceuticals, LLC. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Zydus Lifesciences Limited | ANDA | View NDC → |
| 0.5 mg/mL | Topical | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Kits | ||||
| — | — | PureTek Corporation | UNAPPROVED DRUG OTHER | View NDC → |
Showing 50 of 50 products — FDA National Drug Code Directory. See every product, package size and price: browse all 50 Fluocinonide NDCs →
Fluocinonide side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Fluocinonide — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Fluocinonide are psoriasis, rash, pruritus; about 43% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Fluocinonide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Fluocinonide FDA approval history
How Fluocinonide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Fluocinonide was first approved by the FDA in 1971 (Brand: LIDEX · Alvogen); the first generic version was approved in 1987. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Fluocinonide recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Fluocinonide recall since July 2021, covering 3 product listings. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-13… Lots: Lot# AD76250, Exp Date: 6/30/2026. FDA record D-0477-2026 →
- Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-13… Lots: Lot# AD76251, Exp Date: 6/30/2026. FDA record D-0476-2026 →
- Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-13… Lots: Lot# AD76252, Exp Date: 6/30/2026. FDA record D-0475-2026 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Oct 8, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 4462 4 dose forms · 6 strengths
-
Dose form (SCDF) Topical Cream RxCUI 378617In current FDA listingsClinical drug / strength (SCD) Emollient fluocinonide 0.5 MG/MLRxCUI 18012830.5 MG/MLRxCUI 1034561 MG/MLRxCUI 485647 -
Dose form (SCDF) Topical Gel RxCUI 379077In current FDA listingsClinical drug / strength (SCD) 0.0005 MG/MGRxCUI 310362 -
Dose form (SCDF) Topical Ointment RxCUI 372222In current FDA listingsClinical drug / strength (SCD) 0.0005 MG/MGRxCUI 103457 -
Dose form (SCDF) Topical Solution RxCUI 385001In current FDA listingsClinical drug / strength (SCD) 0.5 MG/MLRxCUI 310364
Look up RxCUI 4462 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Fluocinonide supply and shortage status
Whether Fluocinonide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Fluocinonide is not in shortage right now; the FDA has 3 past shortage records for it.
✅No current shortage of Fluocinonide on recordRead the full Fluocinonide shortage page — affected NDCs, other makers, and what to do →
Source: openFDA, from the FDA Drug Shortages database.
💵 What Fluocinonide costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Cream · Topical | 0.5 mg/g | $0.217–$0.367 per gram | NDC details & price history |
| Cream · Topical | 1 mg/g | $0.251–$0.339 per gram | NDC details & price history |
| Ointment · Topical | 0.5 mg/g | $0.206–$0.368 per gram | NDC details & price history |
| Solution · Topical | 0.5 mg/mL | $0.205 per mL | NDC details & price history |
| Gel · Topical | 0.5 mg/g | $0.600–$1.08 per gram | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Fluocinonide brand names
Fluocinonide is sold under 2 brand names in the FDA directory — Vanos, Fluocinol Pak. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Fluocinonide: manufacturers and labelers
24 companies list Fluocinonide products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Sun Pharmaceutical Industries, Inc., A-S Medication Solutions. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Fluocinonide drug class (RxNorm)
Fluocinonide belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Fluocinonide page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Bausch Health US, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →